Childhood cancer survivors often face long-term consequences from the treatments they received during their younger years. These late effects can include cardiovascular disease, endocrine dysfunction, and cognitive impairments, which emerge years after treatment. Continued surveillance and research into the long-term health of survivors are critical for developing strategies to manage these effects. By identifying risk factors for late effects, such as the type of cancer, treatment regimen, and age at diagnosis, healthcare providers can better predict and mitigate these outcomes. This research is essential for improving the quality of life of childhood cancer survivors and ensuring their well-being into adulthood.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States